Clinical and virological implications of A1846T and C1913A/G mutations of hepatitis B virus genome in severe liver diseases

References

• Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–1555.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Hepatology; Chinese Medical Association; Chinese Society of Infectious Diseases; Chinese Medical Association; Hou JL, et al. The guideline of prevention and treatment for chronic hepatitis B: a 2015 update. Zhonghua Gan Zang Bing Za Zhi. 2015;23:888–905.
   PubMedGoogle Scholar
• Thio CL, Guo N, Xie C, et al. Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. Lancet Infect Dis. 2015;15:981–985.
   PubMed Web of Science ®Google Scholar
• Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378:571–583.
   PubMed Web of Science ®Google Scholar
• Fairley CK, Read TR. Vaccination against sexually transmitted infections. Curr Opin Infect Dis. 2012;25:66–72.
   PubMed Web of Science ®Google Scholar
• Buddeberg F, Schimmer BB, Spahn DR. Transfusion-transmissible infections and transfusion-related immunomodulation. Best Pract Res Clin Anaesthesiol. 2008;22:503–517.
   PubMedGoogle Scholar
• Liu Q, Liu Z, Wang T, et al. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroenterol Hepatol. 2007;22:2101–2106.
   PubMed Web of Science ®Google Scholar
• Ocama P, Opio CK, Lee WM. Hepatitis B virus infection: current status. Am J Med. 2005; 118:1413.
   PubMedGoogle Scholar
• Khudyakov Y. Coevolution and HBV drug resistance. Antivir Ther (Lond). 2010;15:505–515.
   PubMedGoogle Scholar
• Lok AS, Zoulim F, Locarnini S, et al. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology. 2007;46:254–265.
   PubMed Web of Science ®Google Scholar
• Chen RY, Edwards R, Shaw T, et al. Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro. Hepatology. 2003;37:27–35.
   PubMed Web of Science ®Google Scholar
• Yuan JM, Ambinder A, Fan Y, et al. Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2009;18:590–594.
   PubMed Web of Science ®Google Scholar
• Li MS, Lau TC, Chan SK, et al. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity. PLoS One. 2011;6:e21856.
   PubMed Web of Science ®Google Scholar
• Muñoz A, Chen JG, Egner PA, et al. Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China. Carcinogenesis. 2011;32:860–865.
   PubMed Web of Science ®Google Scholar
• Shen T, Yan XM. Hepatitis B virus genetic mutations and evolution in liver diseases. World J Gastroenterol. 2014;20:5435–5441.
   PubMed Web of Science ®Google Scholar
• Jammeh S, Tavner F, Watson R, et al. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol. 2008;89:901–909.
   PubMed Web of Science ®Google Scholar
• Quarleri J. Core promoter: a critical region where the hepatitis B virus makes decisions. World J Gastroenterol. 2014;20:425–435.
   PubMed Web of Science ®Google Scholar
• Yan T, Li K, Li F, et al. T1846 and A/G1913 are associated with acute on chronic liver failure in patients infected with hepatitis B virus genotypes B and C. J Med Virol. 2011;83:996–1004.
   PubMed Web of Science ®Google Scholar
• Zhang A, Wan Z, You S, et al. Association of hepatitis B virus mutations of A1846T and C1913A/G with acute-on-chronic liver failure development from different underlying chronic liver diseases. Hepat Mon. 2013;13:e12445.
   PubMed Web of Science ®Google Scholar
• Xu H, Zhao M, Lou G, et al. New point mutations in surface and core genes of hepatitis B virus associated with acute on chronic liver failure identified by complete genomic sequencing. PLoS One. 2015;10:e0123139.
   PubMed Web of Science ®Google Scholar
• Yang G, Han M, Chen F, et al. Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China. Hepatol Int. 2014;8:508–516.
   PubMed Web of Science ®Google Scholar
• Hu F, Bi S, Yan H, et al. Associations between hepatitis B virus basal core promoter/pre-core region mutations and the risk of acute-on-chronic liver failure: a meta-analysis. Virol J. 2015;12:87.
   PubMed Web of Science ®Google Scholar
• Nian X, Xu Z, Liu Y, et al. Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis. Hepatol Int. 2016;10:606–615.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Infectious Diseases and Parasitology; and Chinese Society of Hepatology. Management scheme of diagnostic and therapy criteria of viral hepatitis. Zhonghua Gan Zang Bing Za Zhi (Chin J Hepatol). 2000;8:324–329.
   Google Scholar
• Xu Z, Ren X, Liu Y, et al. Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. J Gastroenterol. 2011;46:391–400.
   PubMed Web of Science ®Google Scholar
• Li X, Liu Y, Xu Z, et al. A complete genomic analysis of hepatitis B virus isolated from 516 Chinese patients with different clinical manifestations. J Med Virol. 2013;85:1698–1704.
   PubMed Web of Science ®Google Scholar
• Günther S, Li BC, Miska S, et al. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol. 1995;69:5437–5444.
   PubMed Web of Science ®Google Scholar
• Xu Z, Liu Y, Xu T, et al. Acute hepatitis B infection associated with drug-resistant hepatitis B virus. J Clin Virol. 2010;48:270–274.
   PubMed Web of Science ®Google Scholar
• Ji D, Liu Y, Si LL, et al. Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients. Clin Chim Acta. 2011;412:305–313.
   PubMed Web of Science ®Google Scholar
• Ji D, Liu Y, Li L, et al. The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation. J Clin Virol. 2012;54:66–72.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li X, Xin S, et al. The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil. J Viral Hepat. 2015;22:328–334.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu W, Li X, et al. Screening and identification of a novel adefovir dipivoxil resistance associated mutation, rtN236V, of HBV from a large cohort of HBV-infected patients. Antivir Ther. 2014;19:551–558.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xin S, Ye X, et al. Increased occurrence of mutant rtI233V of HBV in patients receiving adefovir therapy. Antivir Ther. 2016;21:9–16.
   PubMed Web of Science ®Google Scholar
• Xu Z, Liu Y, Liu L, et al. Association of interferon-gamma induced protein 10 promoter polymorphisms with the disease progression of hepatitis B virus infection in Chinese han population. PLoS One. 2013;8:e72799.
   PubMedGoogle Scholar
• Katoonizadeh A, Laleman W, Verslype C, et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut. 2010;59:1561–1569.
   PubMed Web of Science ®Google Scholar
• Yin J, Xie J, Liu S, et al. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol. 2011;106:81–92.
   PubMed Web of Science ®Google Scholar
• Chen EQ, Zeng F, Zhou LY, et al. Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure. World J Gastroenterol. 2015;21:11964–11973.
   PubMed Web of Science ®Google Scholar
• Parekh S, Zoulim F, Ahn SH, et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol. 2003;77:6601–6612.
   PubMed Web of Science ®Google Scholar
• Liu CJ, Cheng HR, Chen CL, et al. Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs. C. J Viral Hepat. 2011;18:e482–e490.
   PubMed Web of Science ®Google Scholar
• Qin Y, Tang X, Garcia T, et al. Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity. J Virol. 2011;85:10167–10177.
   PubMed Web of Science ®Google Scholar
• Liu S, Zhang H, Gu C, et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst. 2009;101:1066–1082.
   PubMedGoogle Scholar
• Lee JH, Han KH, Lee JM, et al. Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection. Clin Vaccine Immunol. 2011;18:914–921.
   PubMed Web of Science ®Google Scholar
• Wu JF, Ni YH, Lin YT, et al. Human interleukin-10 genotypes are associated with different precore/core gene mutation patterns in children with chronic hepatitis B virus infection. J Pediatr. 2011;158:808–813.
   PubMed Web of Science ®Google Scholar
• Le Pogam S, Yuan TT, Sahu GK, et al. Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. J Virol. 2000;74:9099–9105.
   PubMed Web of Science ®Google Scholar
• Pollicino T, Cacciola I, Saffioti F, et al. Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications. J Hepatol. 2014;61:408–417.
   PubMed Web of Science ®Google Scholar